...
首页> 外文期刊>Bariatric Surgical Patient Care >Efficacy of Intravenous Acetaminophen in Length of Stay and Postoperative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery Patients
【24h】

Efficacy of Intravenous Acetaminophen in Length of Stay and Postoperative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery Patients

机译:静脉乙酰乙酰乙酰苯氨基酚在腹腔镜Roux-Zh-Y胃旁路手术患者中保持术后术后疼痛和术后疼痛控制的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Opiate-based pain medications may incur adverse effects following bariatric surgery. The aim of this study was to evaluate the efficacy of intravenous Acetaminophen (IVAPAP) on length of stay (LOS) after laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery. Methods: This was a prospective, double-blind, randomized controlled trial conducted from October 2011 to March 2014 at a 416-bed teaching hospital. Eighty-nine total patients were included (control group, n=45; treatment group, n=44). Patients were administered either 1000mg of IVAPAP or placebo every 6h beginning preoperatively and continuing for four doses. LOS, total narcotic consumption, pain and nausea scores, time to return of flatus (ROF), and postoperative rescue pain medication used were measured during the first 24h after surgery. Results: LOS was significantly decreased in the treatment group compared with control (2.72 days vs. 3.18 days; p=0.03). There was significant reduction in time to ROF (1.87 days vs. 2.24 days; p=0.04). Pain was significantly decreased in the first 2 postoperative hours in the treatment group (p=0.02). Total opioid consumption, postoperative nausea scores, and use of rescue pain medications were not affected. Conclusions: The use of IVAPAP significantly decreases LOS following LRYGB, improves acute postoperative pain control, and mediates quicker return of bowel function.
机译:背景:阿片类疼痛药物可能在畜牧手术后产生不利影响。本研究的目的是评估静脉注射乙酰乙酰苯酚(IVAPAP)在腹腔镜Roux-en-ZE-Y胃旁路(LryGB)手术后的静止长度(LOS)的疗效。方法:这是从2011年10月到2014年3月在416床教教学医院的前瞻性双盲随机对照试验。包括八十九个总患者(对照组,N = 45;治疗组,n = 44)。每6小时术前开始施用1000mg的IVAPAP或安慰剂,并继续进行四个剂量。洛杉矶,总麻醉消费,疼痛和恶心评分,术语返回的时间(ROF)和术后抢救疼痛药物在手术后的第一个24H期间测量。结果:与对照相比,治疗组LOS显着降低(2.72天与3.18天; P = 0.03)。对ROF有显着还原(1.87天与2.24天; P = 0.04)。在治疗组的前2小时内疼痛显着降低(P = 0.02)。总阿片类药物消费,术后恶心评分,以及使用救援疼痛药物不受影响。结论:使用IVAPAP的使用显着降低了LRYGB之后的LOS,改善了急性术后疼痛控制,并介导更快的肠功能返回。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号